| Element List | Explanation |
|---|---|
| Announcement Detail | Reference to the results of the Ordinary General Assembly Meeting of the National Medical Care Company held on 10 Rabi’ Al-Awwal 1447H (corresponding to 02 September 2025), during which the members of the Board of Directors were elected for the new term commencing on 15 September 2025 for a duration of four Gregorian years, ending on 14 September 2029. The Company announces the resolutions of the Board of Directors issued, 23 Rabi’ Al-Awwal 1447H (corresponding to 15 September 2025), as follows: 1. Appointment of Mr. Ahmed Wazaa Al-Qahtani (Non-Executive Member) as Chairman of the Board of Directors. 2. Appointment of Mr. Faraj Saad Al-Qabani (Non-Executive Member) as Vice Chairman of the Board of Directors. 3. Appointment of Dr. Abdulaziz Saleh Al-Obaid (Executive Member) as Managing Director and Chief Executive Officer. 4. Formation of the Executive Committee comprising the following members: Dr. Abdulaziz Saleh Al-Obaid (Executive Member) - Mr. Sami Suliman Al-Kashan (Independent Member)- Mr. Faraj Saad Al-Qabani (Non-Executive Member)- Dr. Salman Abbas Al-Rawaf (Independent Member) 5. Formation of the Nomination and Remuneration Committee comprising the following members: Mr. Ahmed Wazaa Al-Qahtani (Non-Executive Member)- Mrs. May Mohammed Al-Hoshan (Independent Member)- Eng. Bandar Sand Al-Dahmashi (Independent Member) 6. Appointment of Eng. Adel Attallah Al-Jabarti as Secretary to the Board of Directors and its subcommittees. 7. Appointment of Dr. Abdulaziz Saleh Al-Obaid and Eng. Adel Attallah Al-Jabarti as the Company’s representatives with the Capital Market Authority, Saudi Exchange (Tadawul), and the Securities Depository Center Company (Edaa), for all purposes related to the application of the Capital Market Law and its implementing regulations |